On March 31, 2025, the Eastern District of Texas issued a decision in the case brought by the American Clinical Laboratory Association (ACLA) and ...

Food companies across the country may lose their authorization to self-affirm food ingredients, dyes, additives, and ...

The food and beverage industry faces significant regulatory change as HHS Secretary Robert F. Kennedy Jr. directs FDA to ...

NEW YORK CITY, NY / ACCESS Newswire / April 18, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...

NEW YORK CITY, NY / ACCESS Newswire / April 17, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Compounding Pharmacies Market Size and GrowthThe global compounding pharmacies market was worth USD 13.23 billion in 2024 and ...

In another rebuke to federal regulatory overreach, the U.S. District Court for the Eastern District of Texas (“District Court”) has vacated the ...

Homemade pesticides may seem natural and cheap, but they can be ineffective and risky to health, plants, pets and the ...

One attorney said the ruling “isn’t quite the stake in the heart.” The FDA is unlikely to challenge the court’s decision, but ...

The executive order asks for recommendations to promote “a more competitive, efficient, transparent, and resilient ...

The investigation concerns whether Nyxoah and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.